UMD bioengineers develop new technologies to drive next-generation therapies for MS

(University of Maryland) Researchers in the University of Maryland Fischell Department of Bioengineering Jewell Laboratory are using quantum dots -- tiny semiconductor particles commonly used in nanotechnology -- to decipher the features needed to design specific and effective therapies for multiple sclerosis (MS) and other autoimmune diseases.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news